Overview
Angiologix Inc. is a medical diagnostic device company whose revolutionary products diagnose a key marker of cardiovascular disease – endothelial dysfunction. The company will capitalize on the rapidly growing market for cardiovascular diagnostic products by providing its customers – physicians and patients – with tools for the early detection and monitoring of cardiovascular disease. The company envisions that products for the diagnosis of endothelial dysfunction will become as ubiquitous as blood pressure monitors.
Angiologix raised its second round of financing.
5/15/2009Angiologix files a patent protecting its novel diagnostic algorithms for the detection of cardiovascular disease.
3/30/2009Angiologix completes a pilot clinical study at Moscow Medical Academy, Russia.
2/5/2009Angiologix completes a clinical study in Tokyo, Japan.